Nutrigenomics Market Size, Share & Forecast Analysis to 2030

The global nutrigenomics market size w valued at around USD 1 billion in 2025 and expected to grow at a significant CAGR of around 16% during the forecast period from 2026 to 2030. The market is witnessing robust growth, driven by increasing consumer awareness of personalized nutrition and advancements in genetic testing technologies. Rising prevalence of lifestyle-related diseases, coupled with growing demand for preventive healthcare solutions, is accelerating the adoption of nutrigenomics-based dietary recommendations. Furthermore, the integration of artificial intelligence, bioinformatics, and next-generation sequencing is enhancing the accuracy and accessibility of personalized nutrition services, supporting sustained market expansion during the forecast period.

Market Snapshot:

Key Insights:

• The global nutrigenomics market is driven by increasing demand for personalized nutrition solutions that use genetic insights to develop customized dietary recommendations.
• Next-Generation Sequencing (NGS) is the dominant technology segment, supported by its ability to analyze multiple genetic variations and enable accurate gene–nutrient interaction studies.
• Obesity management represents a major application area, as nutrigenomics helps develop personalized weight management strategies based on individual genetic profiles.
• North America holds a leading position in the market due to advanced healthcare infrastructure, strong genomics research capabilities, and high adoption of genetic testing services.

Key Factors Driving the Nutrigenomics Market

The increasing demand for personalized nutrition and preventive healthcare is a major factor driving the growth of the nutrigenomics market. Rising incidences of obesity, diabetes, cardiovascular diseases, and other lifestyle-related disorders have encouraged consumers to adopt DNA-based dietary solutions tailored to their genetic profiles. Advances in genomic sequencing, bioinformatics, and artificial intelligence have significantly improved the accuracy and affordability of nutrigenomic testing, enabling healthcare providers and wellness companies to deliver customized nutrition recommendations. Recent scientific studies also highlight the growing role of multi-omics approaches, integrating genomics, metabolomics, and microbiome analysis to provide more precise dietary interventions.

Another key growth driver is the rapid commercialization of direct-to-consumer (DTC) genetic testing services and strategic collaborations between nutrigenomics companies and nutrition retailers. Consumers are increasingly seeking science-backed wellness solutions that support long-term health management rather than reactive treatment. Reflecting this trend, in June 2025, GenoPalate partnered with The Vitamin Shoppe to expand the availability of its DNA-based personalized nutrition kits, making genetic nutrition testing more accessible to a broader consumer base. Such partnerships, combined with growing investments in precision health and digital wellness platforms, are expected to accelerate the adoption of nutrigenomics worldwide.

Key Growth Drivers:

• Increasing consumer awareness of personalized nutrition and preventive healthcare is significantly boosting the adoption of DNA-based dietary recommendations worldwide.
• Continuous advancements in genomic sequencing, artificial intelligence, and bioinformatics are improving the accuracy, efficiency, and affordability of nutrigenomics solutions.
• Rising prevalence of obesity, diabetes, and cardiovascular diseases is driving demand for genetics-based nutrition strategies to improve long-term health outcomes.

Nutrigenomics Market Restraints

The high cost of genetic testing and personalized nutrition services remains a significant restraint for the nutrigenomics market. Although sequencing technologies have become more affordable over the years, comprehensive DNA-based nutrition assessments and expert consultations are still expensive for many consumers, particularly in developing economies. Limited reimbursement policies and uneven access to advanced genetic testing facilities further restrict widespread adoption, reducing market penetration among price-sensitive populations.

Another major challenge is the growing concern over genetic data privacy, regulatory compliance, and the lack of standardized clinical guidelines. Consumers are often hesitant to share sensitive genetic information due to fears of data misuse and cybersecurity risks. In addition, variations in regulatory frameworks across countries and limited clinical validation for certain gene-diet interactions create uncertainty among healthcare providers and consumers, slowing the broader acceptance of nutrigenomics-based nutrition solutions.

Future Opportunities Reshaping the Nutrigenomics Market’s Evolution

The growing convergence of artificial intelligence, multi-omics technologies, and digital health platforms is creating substantial opportunities for the nutrigenomics market. These innovations enable highly personalized nutrition recommendations by integrating genomic, microbiome, metabolomic, and lifestyle data, improving preventive healthcare outcomes and expanding the adoption of precision nutrition across clinical and consumer settings.

Another significant opportunity lies in expanding clinical research and precision nutrition programs worldwide. A 2025 review published in Genes & Nutrition reported that large-scale clinical studies, including PREDICT, FOOD4ME, and PRECISION-HEALTH, demonstrated significant improvements in weight management, glycemic control, and dietary adherence through personalized nutrition compared with conventional dietary approaches, highlighting the growing commercial potential of nutrigenomics-based interventions.

Key Growth Opportunities:

• Rising adoption of precision nutrition and preventive healthcare is creating new opportunities for DNA-based personalized dietary recommendations globally.
• Expanding integration of artificial intelligence, multi-omics, and digital health platforms is enhancing the effectiveness and accessibility of nutrigenomics solutions.
• Increasing collaborations between healthcare providers, genetic testing companies, and nutrition brands are accelerating the commercialization of personalized nutrition services.

Industry Trends Shaping the Global Nutrigenomics Market

A key trend shaping the nutrigenomics market is the increasing integration of artificial intelligence, multi-omics technologies, and digital health platforms to develop highly personalized nutrition solutions. Companies are combining genomic, microbiome, metabolomic, and lifestyle data to provide accurate dietary recommendations, improve health outcomes, and support preventive healthcare. The growing adoption of precision nutrition approaches is also encouraging the development of advanced platforms that analyze individual genetic variations and dietary responses.

Another significant trend is the growing focus on gene–lifestyle interactions and precision nutrition research to improve personalized dietary interventions. A 2025 article published in Frontiers in Nutrition highlighted that precision nutrition frameworks are increasingly incorporating genetic variants, lifestyle factors, and nutrient interactions to develop more individualized nutrition strategies. These advancements are expected to strengthen the adoption of nutrigenomics by enabling more accurate health predictions and customized dietary management.

Market Segments Insights:

By Technology, the Next-generation Sequencing Segment Dominated the Global Nutrigenomics Market

On the basis of technology, the next-generation sequencing (NGS) segment dominated the global market, driven by its ability to provide comprehensive genetic analysis with high accuracy and efficiency. Unlike conventional testing methods, NGS can identify thousands of genetic variations simultaneously, enabling deeper insights into gene–nutrient interactions, metabolic responses, and personalized dietary requirements. The declining cost of sequencing, advancements in bioinformatics, and increasing research activities in precision nutrition are further supporting the adoption of NGS-based nutrigenomics testing.

The dominance of NGS is further supported by continuous innovations that improve sequencing affordability, accuracy, and scalability for large-scale genomic studies. In October 2025, Pacific Biosciences of California, Inc. announced major advancements for its Revio and Vega sequencing platforms, including new SPRQ-Nx chemistry designed to reduce genome sequencing costs and expand multiomic capabilities. These developments are expected to enhance access to high-quality genomic data and support broader applications of NGS technologies in areas such as personalized healthcare and nutrigenomics research.

By Application, the Obesity Management Sub-category Holds the Largest Share of Global Nutrigenomics Market

On the basis of application, the obesity management is expected to be the dominant application segment in the nutrigenomics market, driven by the rising prevalence of obesity and increasing demand for personalized weight management solutions. Nutrigenomics helps identify genetic variations associated with metabolism, appetite regulation, fat storage, and dietary responses, enabling customized nutrition and treatment strategies based on individual biological profiles. The growing adoption of precision healthcare approaches and increasing consumer interest in DNA-based weight management solutions are further supporting the expansion of this segment.

The dominance of obesity management is further supported by recent innovations in genetic-based weight management solutions. In June 2026, Phenomix Sciences launched the MyPhenome® test directly to patients, allowing individuals to access a genetic obesity test designed to guide weight-loss treatment decisions based on their biology. The test analyzes genetic factors linked to obesity and helps healthcare providers develop personalized treatment pathways, highlighting the growing integration of nutrigenomics into obesity care.

Global Nutrigenomics Market Segmentation:

By Product & Service:

• Reagents & Kits
• Services

By Technology:

• Next-Generation Sequencing (NGS)
• PCR-Based Technologies
• Microarrays
• Others

By Application:

• Obesity Management
• Cardiovascular Health
• Diabetes Management
• Cancer Research
• Sports Nutrition
• Others

By End-User:

• Hospitals & Clinics
• Research Institutes & Academic Centers
• Diagnostic Laboratories

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leading the Global Nutrigenomics Market

Geographically, the North America is expected to be the dominant region in the nutrigenomics market, supported by the strong presence of advanced healthcare infrastructure, leading biotechnology companies, and high adoption of personalized healthcare solutions. The region has witnessed significant growth in genetic testing services due to increasing consumer awareness regarding preventive healthcare, rising demand for personalized nutrition plans, and growing investments in genomics research. Additionally, the availability of advanced sequencing technologies, established research institutions, and favorable adoption of direct-to-consumer genetic testing platforms are further strengthening the regional market position.

The dominance of North America is also driven by increasing collaborations between healthcare providers, genetic testing companies, and nutrition technology firms to expand precision nutrition applications. In 2025, the National Institutes of Health (NIH) continued advancing precision nutrition research through initiatives focused on understanding how genetic, environmental, and lifestyle factors influence individual responses to diet. Such government-backed research efforts are expected to accelerate innovation and adoption of nutrigenomics solutions across North America by supporting evidence-based personalized nutrition approaches.

Competitive Analysis:

The nutrigenomics market is highly competitive, with companies focusing on expanding genetic testing capabilities, developing personalized nutrition platforms, and integrating advanced technologies such as artificial intelligence and bioinformatics. Key players are investing in research and development to improve the accuracy of DNA-based nutrition recommendations and strengthen their market presence through product launches, partnerships, and service expansions. The competitive landscape includes genetic testing companies, biotechnology firms, and personalized nutrition providers offering solutions for weight management, disease prevention, sports nutrition, and overall wellness.

Leading companies in the market include Nutrigenomix Inc., Genova Diagnostics, DNAfit, Habit, GenoPalate, 23andMe Holding Co., MyDNA Life Australia Pty Ltd., and Phenomix Sciences. These players are focusing on direct-to-consumer genetic testing, clinical partnerships, and innovative personalized nutrition solutions to capture growing demand for precision healthcare. Strategic collaborations between genomics companies and healthcare providers, along with advancements in sequencing technologies, are expected to intensify competition and accelerate the adoption of nutrigenomics solutions globally.

Key Companies:

• Nutrigenomix Inc.
• Genova Diagnostics
• GenoPalate
• Phenomix Sciences
• 23andMe Holding Co.
• myDNA Life Australia Pty Ltd.
• DNAfit
• Metagenics, Inc.
• Helix OpCo LLC
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Illumina, Inc.

Global Nutrigenomics Market Outlook

• The market is expected to witness strong growth as increasing consumer demand for personalized nutrition and preventive healthcare drives the adoption of DNA-based dietary solutions.
• Advancements in next-generation sequencing, artificial intelligence, and multi-omics technologies are expected to improve the accuracy and accessibility of personalized nutrition recommendations.
• Growing integration of nutrigenomics with digital health platforms, wearable devices, and telehealth services will create new opportunities for customized health management.
• Rising focus on obesity management, chronic disease prevention, and metabolic health is expected to accelerate the adoption of nutrigenomic testing in clinical and wellness applications.
• Strategic partnerships, product innovations, and expanding direct-to-consumer genetic testing services are likely to strengthen market competition and support global market expansion.

Nutrigenomics Market Frequently Asked Questions (FAQ)